Skip to main content
OpenTrials

Clinical trial condition

Triple-negative Breast Cancer

Explore clinical trials studying Triple-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

78 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Triple-negative Breast Cancer trial results

Not Yet Recruiting

NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer

NCT07178730

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • SLK-Kliniken Heilbronn GmbH, Klinik für Gynäkologie und Geburtshilfe Heilbronn, Baden-Wurttemberg, Germany
  • GRN Gesundheitszentren Rhein-Neckar gGmbH, Brustzentrum Weinheim Weinheim, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Augsburg, Klinik für Frauenheilkunde und Geburtsmedizin Augsburg, Bavaria, Germany
  • Klinikum der Universitaet Muenchen AöR, Frauenheilkunde und Geburtshilfe München, Bavaria, Germany
View all 26 locations
View Trial Details
Completed

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

NCT01805076

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Enloe Medical Center Chico, California, United States
View all 179 locations
View Trial Details
Completed

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

NCT04085276

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • The Fifth Medical Center of PLA General Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Peking University Shougang Hospital Beijing, Beijing Municipality, China
View all 55 locations
View Trial Details
Completed

A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

NCT04148911

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • CEMIC Buenos Aires, Argentina
  • Sanatorio de la Mujer Rosario, Argentina
  • Organizacion Medica de Investigacion San Nicolás, Argentina
  • Instituto de Radiomedicina, IRAM Santiago, Chile
View all 67 locations
View Trial Details

Related conditions